Dr. Lacouture on Dermatologist Communication

Mario E. Lacouture, MD
Published: Tuesday, Dec 04, 2012

Mario E. Lacouture, MD, dermatologist, Memorial Sloan-Kettering Cancer Center, explains the challenges that need to be overcome to improve communication between oncologists and dermatologists.

Lacouture says that one of the major challenges stems from an overall lack of dermatologists. As a result, only 8% of patients who develop a dermatologic side effect will actually see a dermatologist during therapy.

The timing of communication is important as oncologists need to quickly judge whether or not to continue with therapy. At the initial referral to a dermatologist, the oncologist needs to provide information about duration of treatment and type of therapy. This can be used to more accurately determine the cause of the adverse event.

Dermatologists and oncologists have different systems for grading side effects in patients. To provide an accurate classification of adverse events, dermatologists must be aware of the language and terminology used by oncologists.
Mario E. Lacouture, MD, dermatologist, Memorial Sloan-Kettering Cancer Center, explains the challenges that need to be overcome to improve communication between oncologists and dermatologists.

Lacouture says that one of the major challenges stems from an overall lack of dermatologists. As a result, only 8% of patients who develop a dermatologic side effect will actually see a dermatologist during therapy.

The timing of communication is important as oncologists need to quickly judge whether or not to continue with therapy. At the initial referral to a dermatologist, the oncologist needs to provide information about duration of treatment and type of therapy. This can be used to more accurately determine the cause of the adverse event.

Dermatologists and oncologists have different systems for grading side effects in patients. To provide an accurate classification of adverse events, dermatologists must be aware of the language and terminology used by oncologists.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesJan 30, 20182.0
Medical Crossfire®: The Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancers – Current Strategies and Future DirectionJan 30, 20181.5
Publication Bottom Border
Border Publication
x